FDA Inspection 1282250 — Egress Capital Partners Inc.
The FDA completed an inspection of Egress Capital Partners Inc. on Sep 15, 2025 in New Rochelle, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 15, 2025
- Fiscal Year
- 2025
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- New Rochelle, NY (United States)